Disseminated intravascular coagulation (DIC) is an acquired syndrome characterized by
widespread intravascular activation of coagulation that can be caused by infectious insults …

Malignancy affects the hemostatic system and the hemostatic system affects malignancy. In
cancer patients there are a number of coagulation abnormalities which provide the …

The demand for platelets in England was stable at around 220,000 adult therapeutic doses
(ATD) per year until 2007/8 at which point demand has increased year on year to 275,000 …

Disseminated intravascular coagulation (DIC) is a syndrome characterized by the systemic
activation of blood coagulation, which generates intravascular fibrin, leading to thrombosis …

The diagnosis of disseminated intravascular coagulation (DIC) should encompass both
clinical and laboratory information. The International Society for Thrombosis and …

Disseminated intravascular coagulation (DIC) is categorized into bleeding, organ failure,
massive bleeding, and non-symptomatic types according to the sum of vectors for …

The introduction of all-trans retinoic acid (ATRA) and, more recently, arsenic trioxide (ATO)
into the therapy of acute promyelocytic leukemia (APL) has revolutionized the management …

In cancer patients, thrombocytopenia can result from bone marrow infiltration or from
anticancer medications and represents an important limitation for the use of antithrombotic …

The incidence of early death in a large population of unselected patients with acute
promyelocytic leukemia (APL) remains unknown because of the paucity of outcome data …

Our knowledge about acute promyelocytic leukemia (APL) patients is mainly based on data
from clinical trials, whereas population-based information is scarce. We studied APL patients …